Cite

HARVARD Citation

    Chung, M. et al. (2022). A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis. Rheumatology. pp. 2441-2449. [Online]. 
  
Back to record